Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol.
about
Optimization of the bacterial cytochrome P450 BM3 system for the production of human drug metabolitesPharmacology of AH 5158; a drug which blocks both - and -adrenoceptorsEarly dose response analysis of ocular hypotensive effects of propranolol in patients with ocular hypertensionReceptor occupancy in lumbar CSF as a measure of the antagonist activity of atenolol, metoprolol and propranolol in the CNS.Plasma levels of (+) and (-)-propranolol and 4-hydroxypropranolol after administration of racemic (+/-)-propranolol in manPlasma concentrations of propranolol and 4-hydroxypropranolol during chronic oral propranolol therapy.Stereoselective ring oxidation of propranolol in man.A class experiment in clinical pharmacology using beta-adrenoceptor antagonist drugs.Comparison of propranolol and Ro 3-3528 in hyperthyroid tachycardia and dysrhythmias.The assessment of beta-adrenoceptor blocking drugs in man.Drug level monitoring in paediatric practice.Controlled-release formulations of propranolol and verapamil.A comparison of the haemodynamic effects of propranolol, 4-hydroxypropranolol and practolol in anaesthetized dogs.The electropharmacology of acute drug testing using pacemakers.Investigation of the safe withdrawal period for propranolol in patients scheduled for open heart surgeryAdaptational responses to prolonged beta-adrenoceptor blockade in adult rabbits.Plasma levels and beta-adrenoceptor blockade with acebutolol, practolol and propranolol in man.The relationship between debrisoquine oxidation phenotype and the pharmacokinetics and pharmacodynamics of propranolol.Contrasts between pindolol and propranolol concentration-response relationships.Enantioselective analysis of propranolol and 4-hydroxypropranolol by CE with application to biotransformation studies employing endophytic fungi.Box-Behnken design for the optimization of an enantioselective method for the simultaneous analysis of propranolol and 4-hydroxypropranolol by CE.High-performance liquid chromatographic analysis of the sulfation of 4-hydroxypropranolol enantiomers by monkey liver cytosol.Rabbit hepatocytes in primary culture: preparation, viability and use in studies of propranolol metabolism.The antagonism by propranolol and alpha-methylpropranolol (ICI 77602) of vascular and cardiac responses to isoprenaline in anaesthetized dogs.Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450.The β3 -adrenoceptor agonist mirabegron increases human atrial force through β1 -adrenoceptors: an indirect mechanism?Anaesthetic problems associated with the treatment of cardiovascular disease: II. Beta-adrenergic antagonists.New approach to assessment of cardioselectivity of beta-blocking drugs.
P2860
Q27027286-7697572F-FF74-443B-9E47-73EC13F57295Q28363276-B1CF5152-1F9C-4F10-B4AE-81E959D1B1BFQ33649865-562415A1-58DE-49C4-8B72-0681857E0000Q34404301-8F117E2A-86B8-4064-BB31-96327D002A7AQ34511604-933CC367-6798-4C83-ACEC-7B0FB868988AQ34518018-BCB09D73-A5D9-46BB-BF13-630ED1E692ECQ34621657-059F72E6-30F1-4113-BF22-3F5702BB1F9DQ34622290-27C702EA-37D9-4F54-BC3C-B742E0232AECQ36809480-D533A9EF-079A-4812-8E10-F10619560439Q37685426-00D3134C-C94D-4D69-8F99-C264F2BFA09EQ38914642-1E9431E2-6024-4F10-A6F6-921C7BC87644Q39679813-2DE5737C-1575-47ED-896E-9F3F119CACC7Q39994386-DBA8556B-76BD-434D-B42A-13678F638681Q40104114-15E656C9-5059-4C19-A89F-4C81A7739185Q41326230-D1FA7079-5036-4FFD-832C-7111E21BF53CQ42024161-369ABF31-4F0F-43DC-80BF-A2C9CED53BFFQ42032581-BA00D7D8-48BF-4682-9C29-FD3EC43EE827Q42532004-0D285507-3FD9-4531-A67C-DA3E967BB7D5Q43240353-B1BE697F-42F5-4438-9C77-A0CCD3CAEED9Q43251999-25881AB3-8DC0-448E-8958-D515873E4629Q43289828-352285CA-6220-4127-99E4-1E670C5ED974Q43554672-42C4FF98-453E-4868-8BA7-BC86E6D10DE3Q43835136-9D6BDF46-E03B-4356-825A-8B9B600F9842Q44002681-3E0AA8F2-8547-4AAB-AE18-A61EAA6AAF0CQ46752739-E4C4015D-6D1E-42A2-96F8-CFF5885C561CQ48060386-42784534-38C8-4C89-B0C9-827CD018B47DQ51868908-2A56B9E1-4E39-4571-A11A-52042339523FQ54632946-161B782D-A858-4271-802D-7F4B16798716
P2860
Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol.
description
1971 nî lūn-bûn
@nan
1971 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1971 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1971年の論文
@ja
1971年論文
@yue
1971年論文
@zh-hant
1971年論文
@zh-hk
1971年論文
@zh-mo
1971年論文
@zh-tw
1971年论文
@wuu
name
Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol.
@ast
Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol.
@en
type
label
Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol.
@ast
Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol.
@en
prefLabel
Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol.
@ast
Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol.
@en
P2860
P1476
Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol.
@en
P2093
Fitzgerald JD
O'Donnell SR
P2860
P304
P356
10.1111/J.1476-5381.1971.TB07171.X
P407
P577
1971-09-01T00:00:00Z